Disruption of Oncogene/Tumor Suppressor Networks During Human Carcinogenesis

REFERENCES

• Nevins J.R., Vogt P.K. Cell Transformation by Viruses. Fundamental Virology, B.N. Fields, D.M. Knipe, P.M. Howley. 3rd Ed., Lippincott-Raven, Philadelphia 1996; 267–309
   Google Scholar
• Evan G.I., Wyllie A.H., Gilbert C.S., Littlewood T.D., Land H., Brooks M., , et al. Induction of Apoptosis in Fibroblasts by c-myc Protein. Cell 1992; 69: 119–128
   PubMed Web of Science ®Google Scholar
• Serrano M., Lin A.W., McCurrach M.E., Beach D., Lowe S.W. Oncogenic Ras Provokes Premature Cell Senescence Associated with Accumulation of p53 and p16INK4a. Cell 1997; 88: 593–602
   PubMed Web of Science ®Google Scholar
• Armitage P., Doll R. The Age Distribution of Cancer and a Multi-Stage Theory of Carcinogenesis. Br. J. Cancer 1954; 8: 1–12
   PubMed Web of Science ®Google Scholar
• Yuspa S.H., Hennings H., Saffiotti U. Cutaneous Chemical Carcinogenesis: Past, Present, and Future. J. Invest. Dermatol. 1976; 67: 199–208
   PubMed Web of Science ®Google Scholar
• Land H., Parada L.F., Weinberg R.A. Tumorigenic Conversion of Primary Embryo Fibroblasts Requires at Least Two Cooperating Oncogenes. Nature 1983; 304: 596–602
   PubMed Web of Science ®Google Scholar
• Ruley H.E. Adenovirus Early Region 1A Enables Viral and Cellular Transforming Genes to Transform Primary Cells in Culture. Nature 1983; 304: 602–606
   PubMed Web of Science ®Google Scholar
• Hahn W.C., Counter C.M., Lundberg A.S., Beijersbergen R.L., Brooks M.W., Weinberg R.A. Creation of Human Tumor Cells with Defined Genetic Elements. Nature 1999; 400: 464–468
   PubMed Web of Science ®Google Scholar
• Vogelstein B., Kinzler K.W. The Multistep Nature of Cancer. Trends Genet. 1993; 9: 138–141
   PubMed Web of Science ®Google Scholar
• Vogelstein B., Fearon E.R., Hamilton S.R., Kern S.E., Preisinger A.C., Leppert M., , et al. Genetic Alterations During Colorectal-Tumor Development. New Engl. J. Med. 1988; 319: 525–532
   PubMed Web of Science ®Google Scholar
• Lander E.S., Weinberg R.A. Genomics: Journey to the Center of Biology. Science 2000; 287: 1777–1782
   PubMed Web of Science ®Google Scholar
• Scherf U., Ross D.T., Waltham M., Smith L.H., Lee J.K., Tanabe L., , et al. A Gene Expression Database for the Molecular Pharmacology of Cancer (see comments). Nat. Genet. 2000; 24: 236–244
   PubMed Web of Science ®Google Scholar
• Knudson A.G., Jr., Meadows A.T., Nichols W.W., Hill R. Chromosomal Deletion and Retinoblastoma. New Engl. J. Med. 1976; 295(20)1120–1123
   PubMed Web of Science ®Google Scholar
• Knudson A.G., Jr. Mutation and Cancer: Statistical Study of Retinoblastoma. Proc. Natl. Acad. Sci. USA 1971; 68(4)820–823
   PubMed Web of Science ®Google Scholar
• Gateff E. Tumor Suppressor and Overgrowth Suppressor Genes of Drosophila Melanogaster: Developmental Aspects. Int. J. Dev. Biol. 1994; 38: 565–590
   PubMed Web of Science ®Google Scholar
• De Lorenzo C., Mechler B.M., Bryant P.J. What is Drosophila Telling Us About Cancer?. Cancer Metastasis Rev. 1999; 18: 295–311
   Google Scholar
• Friend S.H., Bernards R., Rogelj S., Weinberg R.A., Rapaport J.M., Albert D.M., , et al. A Human DNA Segment with Properties of the Gene that Predisposes to Retinoblastoma and Osteosarcoma. Nature 1986; 323: 643–646
   PubMed Web of Science ®Google Scholar
• Harlow E., Whyte P., Franza B.R., Schley C. Association of Adenovirus Early Region 1A Proteins With Cellular Polypeptides. Mol. Cell. Biol. 1986; 6: 1579–1589
   PubMed Web of Science ®Google Scholar
• Yee S., Branton P.E. Detection of Cellular Proteins Associated with Human Adenovirus Type 5 Early Region E1A Polypeptides. Virology 1985; 147: 142–153
   PubMed Web of Science ®Google Scholar
• Stehelin D., Guntaka R.V., Varmus H.E., Bishop J.M. Purification of DNA Complementary to Nucleotide Sequences Required for Neoplastic Transformation of Fibroblasts by Avian Sarcoma Viruses. J. Mol. Biol. 1976; 101: 349–365
   PubMed Web of Science ®Google Scholar
• Stehelin D., Varmus H.E., Bishop J.M., Vogt P.K. DNA Related to The Transforming Gene(s) of Avian Sarcoma Viruses is Present in Normal Avian DNA. Nature 1976; 260: 170–173
   PubMed Web of Science ®Google Scholar
• Courtneidge S.A., Smith A.E. Polyoma Virus Transforming Protein Associates with the Product of the c-src Cellular Gene. Nature 1983; 303: 435–439
   PubMed Web of Science ®Google Scholar
• Lane D.P., Crawford L.V. T Antigen is Bound to a Host Protein in SV40-Transformed Cells. Nature 1979; 278: 261–263
   PubMed Web of Science ®Google Scholar
• Linzer D.I.H., Levine A.J. Characterization of a 54 k Dalton Cellular SV40 Tumor Antigen Present in SV40-Transformed Cells and Uninfected Embryonal Carcinoma Cells. Cell 1979; 17: 43–52
   PubMed Web of Science ®Google Scholar
• Sarnow P., Ho Y.S., Williams J., Levine A.J. Adenovirus E1b-58kD Tumor Antigen and SV40 Large Tumor Antigen are Physically Associated with the Same 54 kD Cellular Protein in Transformed Cells. Cell 1982; 28: 387–394
   PubMed Web of Science ®Google Scholar
• Whyte P., Buchkovich K.J., Horowitz J.M., Friend S.H., Raybuck M., Weinberg R.A., , et al. Association Between an Oncogene and an Antioncogene: The Adenovirus E1A Proteins Bind to the Retinoblastoma Gene Product. Nature 1988; 334: 124–129
   PubMed Web of Science ®Google Scholar
• Weinberg R.A. The Cat and Mouse Games that Genes, Viruses, and Cells Play. Cell 1997; 88: 573–575
   PubMed Web of Science ®Google Scholar
• DeCaprio J.A., Ludlow J.W., Figge J., Shew J.Y., Huang C.M., Lee W.H., , et al. SV40 Large Tumor Antigen Forms a Specific Complex with the Product of the Retinoblastoma Susceptibility Gene. Cell 1988; 54: 275–283
   PubMed Web of Science ®Google Scholar
• Dyson N., Howley P.M., Münger K., Harlow E. The Human Papillomavirus-16 E7 Oncoprotein Is Able to Bind to the Retinoblastoma Gene Product. Science 1989; 243: 934–937
   PubMed Web of Science ®Google Scholar
• Phelps W.C., Yee C.L., Münger K., Howley P.M. The Human Papillomavirus Type 16 E7 Gene Encodes Transactivation and Transformation Functions Similar to Adenovirus E1a. Cell 1988; 53: 539–547
   PubMed Web of Science ®Google Scholar
• Defeo-Jones D., Huang P.S., Jones R.E., Haskell K.M., Vuocolo G.A., Hanobik M.G., , et al. Cloning of cDNAs for Cellular Proteins that Bind to the Retinoblastoma Gene Product. Nature 1991; 352: 251–254
   PubMed Web of Science ®Google Scholar
• Kaelin W.G., Jr., Pallas D.C., DeCaprio J.A., Kaye F.J., Livingston D.M. Identification of Cellular Proteins that Can Interact Specifically with the T/E1A-Binding Region of the Retinoblastoma Gene Product. Cell 1991; 64: 521–532
   PubMed Web of Science ®Google Scholar
• Buchkovich K., Duffy L.A., Harlow E. The Retinoblastoma Protein is Phosphorylated During Specific Phases of the Cell Cycle. Cell 1989; 58: 1097–1105
   PubMed Web of Science ®Google Scholar
• DeCaprio J.A., Ludlow J.W., Lynch D., Furukawa Y., Griffin J., Piwnica-Worms H., , et al. The Product of the Retinoblastoma Susceptibility Gene has Properties of a Cell Cycle Regulatory Element. Cell 1989; 58: 1085–1095
   PubMed Web of Science ®Google Scholar
• Lin B.T.-Y., Gruenwald S., Morla A.O., Lee W.-H., Wang J.Y.J. Retinoblastoma Cancer Suppressor Gene Product is a Substrate of the Cell Cycle Regulator cdc2 Kinase. EMBO J. 1991; 10: 857–864
   PubMed Web of Science ®Google Scholar
• Roberts J.M. Evolving Ideas About Cyclins. Cell 1999; 98: 129–132
   PubMed Web of Science ®Google Scholar
• Sherr C.J. Cancer Cell Cycles. Science 1996; 274: 1672–1677
   PubMed Web of Science ®Google Scholar
• Harbour J.W., Luo R.X., Dei Santi A., Postigo A.A., Dean D.C. Cdk Phosphorylation Triggers Sequential Intramolecular Interactions that Progressively Block Rb Functions as Cells Move Through G1. Cell 1999; 98: 859–869
   PubMed Web of Science ®Google Scholar
• Weinberg R.A. The Retinoblastoma Protein and Cell Cycle Control. Cell 1995; 81: 323–330
   PubMed Web of Science ®Google Scholar
• Weintraub S.J., Prater C.A., Dean D.C. Retinoblastoma Protein Switches the E2F Site from Positive to Negative Element. Nature 1992; 358: 259–261
   PubMed Web of Science ®Google Scholar
• Dyson N. The Regulation of E2F by pRB-Family Proteins. Genes. Dev. 1998; 12: 2245–2262
   PubMed Web of Science ®Google Scholar
• Horowitz J.M., Park S.-H., Bogenmann E., Cheng J.-C., Yandell D.W., Kaye F., , et al. Frequent Inactivation of the Retinoblastoma Anti-Oncogene Is Restricted to a Subset of Human Tumors. Proc. Natl. Acad. Sci. USA 1990; 87: 2775–2779
   PubMed Web of Science ®Google Scholar
• Scheffner M., Münger K., Byrne J.C., Howley P.M. The State of the p53 and Retinoblastoma Genes in Human Cervical Carcinoma Cell Lines. Proc. Natl. Acad. Sci. USA 1991; 88: 5523–5527
   PubMed Web of Science ®Google Scholar
• Szepetowski P., Nguyen C., Perucca-Lostanlen D., Carle G.F., Tsujimoto Y., Birnbaum D., , et al. D11S146 and BCL1 Are Physically Linked but Can Be Discriminated by Their Amplification Status in Human Breast Cancer. Genomics 1991; 10(2)410–416
   PubMed Web of Science ®Google Scholar
• Jiang W., Kahn S.M., Tomita N., Zhang Y.J., Lu S.H., Weinstein I.B. Amplification and Expression of the Human Cyclin D Gene in Esophageal Cancer. Cancer Res. 1992; 52: 2980–2983
   PubMed Web of Science ®Google Scholar
• Zukerberg L.R., Yang W.I., Gadd M., Thor A.D., Koerner F.C., Schmidt E.V., , et al. Cyclin D1 (PRAD1) Protein Expression in Breast Cancer: Approximately One-Third of Infiltrating Mammary Carcinomas Show Overexpression of the Cyclin D1 Oncogene. Mod. Pathol. 1995; 8: 560–567
   PubMed Web of Science ®Google Scholar
• Costello J.F., Plass C., Arap W., Chapman V.M., Held W.A., Berger M.S., , et al. Cyclin-Dependent Kinase 6 (CDK6) Amplification in Human Gliomas Identified Using Two-Dimensional Separation of Genomic DNA. Cancer Res. 1997; 57: 1250–1254
   PubMed Web of Science ®Google Scholar
• Timmermann S., Hinds P., Münger K. Elevated Activity of Cyclin-Dependent Kinase 6 in Human Squamous Cell Carcinoma Lines. Cell Growth Differ. 1997; 8: 361–370
   PubMedGoogle Scholar
• Reifenberger G., Reifenberger J., Ichimura K., Meltzer P.S., Collins V.P. Amplification of Multiple Genes from Chromosomal Region 12q13-14 in Human Malignant Gliomas: Preliminary Mapping of the Amplicons Shows Preferential Involvement of CDK4, SAS, and MDM2. Cancer Res. 1994; 54: 4299–4303
   PubMed Web of Science ®Google Scholar
• Khatib Z.A., Matsushime H., Valentine M., Shapiro D.N., Sherr C.J., Look A.T. Coamplification of the CDK4 Gene with MDM2 and GLI in Human Sarcomas. Cancer Res. 1993; 53: 5535–5541
   PubMed Web of Science ®Google Scholar
• Reymond A., Brent R. p16 Proteins from Melanoma-prone Families Are Deficient in Binding to Cdk4. Oncogene 1995; 11(6)1173–1178
   PubMed Web of Science ®Google Scholar
• Hussussian C.J., Struewing J.P., Goldstein A.M., Higgins P.A., Ally D.S., MD, et al. Germline p16 Mutations in Familial Melanoma (see comments). Nat. Genet. 1994; 8: 15–21
   PubMed Web of Science ®Google Scholar
• Kamb A., Shattuck-Eidens D., Eeles R., Liu Q., Gruis N.A., Ding W., , et al. Analysis of the p16 Gene (CDKN2) as a Candidate for the Chromosome 9p Melanoma Susceptibility Locus. Nat. Genet. 1994; 8: 23–26
   PubMed Web of Science ®Google Scholar
• Hebert J., Cayuela J.M., Berkeley J., Sigaux F. Candidate Tumor-Suppressor Genes MTS1 (p16(INK4A)) and MTS2 (p15(INK4B)) Display Frequent Homozygous Deletions in Primary Cells from T- But Not from B-Cell Lineage Acute Lymphoblastic Leukemias. Blood 1994; 84: 4038–4044
   PubMed Web of Science ®Google Scholar
• Weinberg R.A. E2F and Cell Proliferation: A World Turned Upside Down. Cell 1996; 85(4)457–459
   PubMed Web of Science ®Google Scholar
• Sellers W.R., Novitch B.G., Miyake S., Heith A., Otterson G.A., Kaye F.J., , et al. Stable Binding to E2F Is Not Required for the Retinoblastoma Protein to Activate Transcription, Promote Differentiation, and Suppress Tumor Cell Growth. Genes Dev. 1998; 12: 95–106
   PubMed Web of Science ®Google Scholar
• Hurford R.K., Jr., Cobrinik D., Lee M.H., Dyson N. pRB and p107/p130 Are Required for the Regulated Expression of Different Sets of E2F Responsive Genes. Genes Dev. 1997; 11: 1447–1463
   PubMed Web of Science ®Google Scholar
• Claudio P.P., Howard C.M., Fu Y., Cinti C., Califano L., Micheli P., , et al. Mutations in the Retinoblastoma-Related Gene RB2/p130 in Primary Nasopharyngeal Carcinoma. Cancer Res. 2000; 60: 8–12
   PubMed Web of Science ®Google Scholar
• Claudio P.P., Howard C.M., Pacilio C., Cinti C., Romano G., Minimo C., , et al. Mutations in the Retinoblastoma-Related Gene RB2/p130 in Lung Tumors and Suppression of Tumor Growth In Vivo by Retrovirus-Mediated Gene Transfer. Cancer Res. 2000; 60: 372–382
   PubMed Web of Science ®Google Scholar
• Werness B.A., Levine A.J., Howley P.M. Association of Human Papillomavirus Types 16 and 18 E6 Proteins with p53. Science 1990; 248: 76–79
   PubMed Web of Science ®Google Scholar
• DeLeo A.B., Jay G., Appella E., Dubois G.C., Law L.W., Old L.J. Detection of a Transformation-Related Antigen in Chemically Induced Sarcomas and Other Transformed Cells of the Mouse. Proc. Natl. Acad. Sci. USA 1979; 76: 2420–2424
   PubMed Web of Science ®Google Scholar
• Parada L.F., Land H., Weinberg R.A., Wolf D., Rotter V. Cooperation Between Gene Encoding p53 Tumour Antigen and Ras in Cellular Transformation. Nature 1984; 312: 649–651
   PubMed Web of Science ®Google Scholar
• Ben David Y., Prideaux V.R., Chow V., Benchimol S., Bernstein A. Inactivation of the p53 Oncogene by Internal Deletion or Retroviral Integration in Erythroleukemic Cell Lines Induced by Friend Leukemia Virus. Oncogene 1988; 3: 179–185
   PubMed Web of Science ®Google Scholar
• Hinds P., Finlay C., Levine A.J. Mutation is Required to Activate the p53 Gene for Cooperation with the Ras Oncogene and Transformation. J. Virol. 1989; 63: 739–746
   PubMed Web of Science ®Google Scholar
• Finlay C.A., Hinds P.W., Levine A.J. The p53 Protooncogene Can Act as a Suppressor of Transformation. Cell Growth Differ. 1989; 57: 1083–1093
   Google Scholar
• Baker S.J., Fearon E.R., Nigro J.M., Hamilton S.R., Preisinger A.C., Jessup J.M., , et al. Chromosome 17 Deletions and p53 Gene Mutations in Colorectal Carcinomas. Science 1989; 244: 217–221
   PubMed Web of Science ®Google Scholar
• Li F.P., Fraumeni J.F., Jr. Rhabdomyosarcoma in Children: Epidemiologic Study and Identification of a Familial Cancer Syndrome. J. Natl. Cancer. Inst. 1969; 43: 1365–1373
   PubMed Web of Science ®Google Scholar
• Malkin D., Li F.P., Strong L.C., Fraumini J.F., Jr., Nelson C.E., Kim D.H., , et al. Germ Line p53 Mutations in a Familial Syndrome of Breast Cancer, Sarcomas, and Other Neoplasias. Science 1990; 250: 1233–1238
   PubMed Web of Science ®Google Scholar
• Gualberto A., Aldape K., Kozakiewicz K., Tlsty T.D. An Oncogenic Form of p53 Confers a Dominant, Gain-of-Function Phenotype that Disrupts Spindle Checkpoint Control. Proc. Natl. Acad. Sci. USA 1998; 95: 5166–5171
   PubMed Web of Science ®Google Scholar
• Marin M.C., Jost C.A., Brooks L.A., Irwin M.S., O'Nions J., Tidy J.A., , et al. A Common Polymorphism Acts as an Intragenic Modifier of Mutant p53 Behaviour. Nat. Genet. 2000; 25: 47–54
   PubMed Web of Science ®Google Scholar
• Lane D.P. Cancer: p53, Guardian of the Genome. Nature 1992; 358: 15–16
   PubMed Web of Science ®Google Scholar
• Sakaguchi K., Herrera J.E., Saito S., Miki T., Bustin M., Vassilev A., , et al. DNA Damage Activates p53 Through a Phosphorylation–Acetylation Cascade. Genes Dev. 1998; 12: 2831–2841
   PubMed Web of Science ®Google Scholar
• El-Deiry W.S., Tokino T., Velculescu V.E., Levy D.B., Parsons R., Trent J.M., , et al. WAF1, a Potential Mediator of p53 Tumor Suppression. Cell 1993; 75: 817–825
   PubMed Web of Science ®Google Scholar
• Harper J.W., Adami G.R., Wei N., Keyomarsi K., Elledge S.J. The p21 CDK-Interacting Protein cip1 is a Potent Inhibitor of G1 Cyclin-Dependent Kinases. Cell 1993; 75: 805–816
   PubMed Web of Science ®Google Scholar
• Harrington E.A., Bruce J.L., Harlow E., Dyson N. pRB Plays an Essential Role in Cell Cycle Arrest Induced by DNA Damage. Proc. Natl. Acad. Sci. USA 1998; 95: 11945–11950
   PubMed Web of Science ®Google Scholar
• Wagner A.J., Kokontis J.M., Hay N. Myc-Mediated Apoptosis Requires Wild-type p53 in a Manner Independent of Cell Cycle Arrest and the Ability of p53 to Induce p21waf1/cip1. Genes Dev. 1994; 8: 2817–2830
   PubMed Web of Science ®Google Scholar
• Polyak K., Xia Y., Zweier J.L., Kinzler K.W., Vogelstein B. A Model for p53-Induced Apoptosis. Nature 1997; 389: 300–305
   PubMed Web of Science ®Google Scholar
• Miyashita T., Reed J.C. Tumor Suppressor p53 is a Direct Transcriptional Activator of the Human Bax Gene. Cell 1995; 80(2)293–299
   PubMed Web of Science ®Google Scholar
• Oda E., Ohki R., Murasawa H., Nemoto J., Shibue T., Yamashita T., , et al. Noxa, a BH3-only Member of the Bcl-2 Family and Candidate Mediator of p53-Induced Apoptosis. Science 2000; 288: 1053–1058
   PubMed Web of Science ®Google Scholar
• Attardi L.D., Reczek E.E., Cosmas C., Demicco E.G., McCurrach M.E., Lowe S.W., , et al. PERP, an Apoptosis-Associated Target of p53, is a Novel Member of the PMP-22/gas3 Family. Genes Dev. 2000; 14: 704–718
   PubMed Web of Science ®Google Scholar
• Bennett M., Macdonald K., Chan S.W., Luzio J.P., Simari R., Weissberg P. Cell Surface Trafficking of Fas: a Rapid Mechanism of p53-mediated Apoptosis. Science 1998; 282: 290–293
   PubMed Web of Science ®Google Scholar
• Kubbutat M.H., Jones S.N., Vousden K.H. Regulation of p53 stability by Mdm2. Nature 1997; 387: 299–303
   PubMed Web of Science ®Google Scholar
• Haupt Y., Maya R., Kazaz A., Oren M. Mdm2 Promotes the Rapid Degradation of p53. Nature 1997; 387: 296–299
   PubMed Web of Science ®Google Scholar
• Barak Y., Juven T., Haffner R., Oren M. Mdm2 Expression Is Induced by Wild Type p53 Activity. EMBO J. 1993; 12: 46146–46148
   Google Scholar
• Momand J., Zambetti G.P., Olson D.C., George D., Levine A.J. The mdm-2 Oncogene Product Forms a Complex with the p53 Protein and Inhibits p53-mediated Transactivation. Cell 1992; 69(7)1237–1245
   PubMed Web of Science ®Google Scholar
• Honda R., Tanaka H., Yasuda H. Oncoprotein MDM2 Is a Ubiquitin Ligase E3 for Tumor Suppressor p53. FEBS Lett. 1997; 420: 25–27
   PubMed Web of Science ®Google Scholar
• Ladanyi M., Cha C., Lewis R., Jhanwar S.C., Huvos A.G., Healey J.H. MDM2 Gene Amplification in Metastatic Osteosarcoma. Cancer Res. 1993; 53: 16–18
   PubMed Web of Science ®Google Scholar
• Leach F.S., Tokino T., Meltzer P., Burrell M., Oliner J.D., Smith S., , et al. p53 Mutation and MDM2 Amplification in Human Soft Tissue Sarcomas. Cancer Res. 1993; 53: 2231–2234
   PubMed Web of Science ®Google Scholar
• Xiao Z.X., Chen J.D., Levine A.J., Modjtahedi N., Xing J., Sellers W.R., , et al. Interaction Between the Retinoblastoma Protein and the Oncoprotein MDM2. Nature 1995; 375: 694–698
   PubMed Web of Science ®Google Scholar
• Hsieh J.K., Chan F.S., O'Connor D.J., Mittnacht S., Zhong S., Lu X. RB Regulates the Stability and the Apoptotic Function of p53 via MDM2. Mol. Cell. 1999; 3: 181–193
   PubMed Web of Science ®Google Scholar
• Stott F.J., Bates S., James M.C., McConnell B.B., Starborg M., Brookes S., , et al. The Alternative Product from the Human CDKN2A Locus, p14(ARF), Participates in a Regulatory Feedback Loop with p53 and MDM2. EMBO J. 1998; 17: 5001–5014
   PubMed Web of Science ®Google Scholar
• Zhang Y., Xiong Y., Yarbrough W.G. ARF Promotes MDM2 Degradation and Stabilizes p53: ARF-INK4a Locus Deletion Impairs Both the Rb and p53 Tumor Suppression Pathways. Cell 1998; 92: 725–734
   PubMed Web of Science ®Google Scholar
• Quelle D.E., Zindy F., Ashmun R.A., Sherr C.J. Alternative Reading Frames of the INK4a Tumor Suppressor Gene Encode Two Unrelated Proteins Capable of Inducing Cell Cycle Arrest. Cell 1995; 83: 993–1000
   PubMed Web of Science ®Google Scholar
• Bates S., Phillips A.C., Clark P.A., Stott F., Peters G., Ludwig R.L., , et al. p14ARF Links the Tumour Suppressors RB and p53. Nature 1998; 395: 124–125
   PubMed Web of Science ®Google Scholar
• Sherr C.J., Weber J.D. The ARF/p53 Pathway. Curr. Opin. Genet. Dev. 2000; 10: 94–99
   PubMed Web of Science ®Google Scholar
• Inoue K., Roussel M.F., Sherr C.J. Induction of ARF Tumor Suppressor Gene Expression and Cell Cycle Arrest by Transcription Factor DMP1. Proc. Natl. Acad. Sci. USA 1999; 96: 3993–3998
   PubMed Web of Science ®Google Scholar
• Hirai H., Sherr C.J. Interaction of D-type Cyclins with a Novel Myb-like Transcription Factor, DMP1. Mol. Cell Biol. 1996; 16: 6457–6467
   PubMed Web of Science ®Google Scholar
• Ruas M., Peters G. The p16INK4a/CDKN2A Tumor Suppressor and Its Relatives. BBA Rev. Cancer 1998; 1378(2)F115–F177
   Google Scholar
• Campisi J. Cancer, Aging and Cellular Senescence. In Vivo 2000; 14: 183–188
   PubMed Web of Science ®Google Scholar
• Lundblad V., Blackburn E.H. An Alternative Pathway for Yeast Telomere Maintenance Rescues est1-Senescence. Cell 1993; 73: 347–360
   PubMed Web of Science ®Google Scholar
• Kim N.W., Piatyszek M.A., Prowse K.R., Harley C.B., West M.D., Ho P.L., , et al. Specific Association of Human Telomerase Activity with Immortal Cells and Cancer. Science 1994; 266: 2011–2015
   PubMed Web of Science ®Google Scholar
• Wang J., Xie L.Y., Allan S., Beach D., Hannon G.J. Myc Activates Telomerase. Genes Dev. 1998; 12(12)1769–1774
   PubMed Web of Science ®Google Scholar
• Wu K.J., Grandori C., Amacker M., Simon-Vermot N., Polack A., Lingner J., , et al. Direct Activation of TERT Transcription by c-MYC. Nat. Genet. 1999; 21: 220–224
   PubMed Web of Science ®Google Scholar
• Wang J., Hannon G.J., Beach D.H. Risky Immortalization by Telomerase. Nature 2000; 405: 755–756
   PubMed Web of Science ®Google Scholar
• Klingelhutz A.J., Foster S.A., McDougall J.K. Telomerase Activation by the E6 Gene Product of Human Papillomavirus Type 16. Nature 1996; 380: 79–82
   PubMed Web of Science ®Google Scholar
• Bodnar A.G., Ouellette M., Frolkis M., Holt S.E., Chiu C.P., Morin G.B., , et al. Extension of Life-Span by Introduction of Telomerase into Normal Human Cells. Science 1998; 279: 349–352
   PubMed Web of Science ®Google Scholar
• Kiyono T., Foster S.A., Koop J.I., McDougall J.K., Galloway D.A., Klingelhutz A.J. Both Rb/p16INK4a Inactivation and Telomerase Activity Are Required to Immortalize Human Epithelial Cells (see comments). Nature 1988; 396: 84–88
   Google Scholar
• Artandi S.E., Chang S., Lee S.L., Alson S., Gottlieb G.J., Chin L., , et al. Telomere Dysfunction Promotes Non-reciprocal Translocations and Epithelial Cancers in Mice. Nature 2000; 406: 641–645
   PubMed Web of Science ®Google Scholar
• Hanahan D. Benefits of Bad Telomeres. Nature 2000; 406: 573–574
   PubMed Web of Science ®Google Scholar
• Sen S. Aneuploidy and Cancer. Curr. Opin. Oncol. 2000; 12: 82–88
   PubMed Web of Science ®Google Scholar
• Nowell P.C. The Clonal Evolution of Tumor Cell Populations. Science 1976; 194: 23–28
   PubMed Web of Science ®Google Scholar
• Livingstone L.R., White A., Sprouse J., Livanos E., Jacks T., Tlsty T.D. Altered Cell Cycle Arrest and Gene Amplification Potential Accompany Loss of Wild-type p53. Cell 1992; 70: 923–935
   PubMed Web of Science ®Google Scholar
• Hashida T., Yasumoto S. Induction of Chromosomal Abnormalities in Mouse and Human Epidermal Keratinocytes by the Human Papillomavirus Type 16 E7 Oncogene. J. Gen. Virol. 1991; 72: 1569–1577
   PubMed Web of Science ®Google Scholar
• Urbani L., Stearns T. The Centrosome. Curr. Biol. 1999; 9: R315–R317
   Google Scholar
• Meraldi P., Lukas J., Fry A.M., Bartek J., Nigg E.A. Centrosome Duplication in Mammalian Somatic Cells Requires E2F and Cdk2-cyclin A. Nat. Cell. Biol. 1999; 1: 88–93
   PubMed Web of Science ®Google Scholar
• Duensing S., Lee L.Y., Duensing A., Basile J., Piboonniyom S., Gonzalez S., , et al. The Human Papillomavirus Type 16 E6 and E7 Oncoproteins Cooperate to Induce Mitotic Defects and Genomic Instability by Uncoupling Centrosome Duplication from the Cell Division Cycle. Proc. Natl. Acad. Sci. USA 2000; 97: 10002–10007
   PubMed Web of Science ®Google Scholar
• Cahill D.P., Kinzler K.W., Vogelstein B., Lengauer C. Genetic Instability and Darwinian Selection in Tumours. Trends Cell Biol. 1999; 9: M57–M60
   PubMed Web of Science ®Google Scholar